Indicators of quality of care provided to patients with dementia
| Measure of care | n (%) |
|---|---|
| Annual dementia review (n = 745)a | |
| Received review | 599 (80) |
| Completed by: | |
| GP | 263 (44) |
| Old age psychiatrist | 153 (26) |
| Other health professional | 25 (4) |
| No record | 158 (26) |
| Mental health review | 513 (86) |
| Medication review | 419 (70) |
| Discussion with carers | 367 (61) |
| Social care review | 305 (51) |
| Median (IQR) for annual review quality score % | 60 (20–100) |
| Management of cognitive symptoms | |
| Patients with Alzheimer’s disease (n = 422), prescribed cholinesterase inhibitors | 325 (77) |
| Plus checked for eligibility | 364 (86) |
| Management of depression | |
| Patients with diabetes mellitus and/or coronary heart disease (n = 146) for whom case finding for depression has been undertaken using two standard screening questionsa | 81 (55) |
| Patients with a new diagnosis of depression (n = 89), with an assessment of severity at outset of treatment | 10 (11) |
| Management of BPSD with antipsychotics (n = 994) | |
| Patients prescribed antipsychotics | |
| Current | 259 (26) |
| Median duration of use (IQR), months | 23 (8–42) |
| For >15 months | 129 (13) |
| Reviewed in last 6 monthsb | 66 (51) |
| Reviewed in last last 15 monthsb | 99 (77) |
| Reason for prescription | |
| Hallucinations and/or delusions | 70 (27) |
| Other (without hallucinations/delusions) | |
| Agitation | 72 (28) |
| Aggression | 69 (27) |
| Confusion | 51 (20) |
| Wandering | 45 (17) |
| Median (IQR) number of applicable indicators for the calculation of the overall care score | 5 (2–6) |
| Mean (SD) overall care score, % | 62 (33) |